Treace Begin Period Cash Flow from 2010 to 2024
| TMCI Stock | USD 7.50 0.13 1.70% |
Begin Period Cash Flow | First Reported 2010-12-31 | Previous Quarter 19.5 M | Current Value 34.5 M | Quarterly Volatility 27.4 M |
Check Treace Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Treace Medical's main balance sheet or income statement drivers, such as Net Interest Income of 202.7 K, Interest Income of 5.6 M or Depreciation And Amortization of 2.8 M, as well as many indicators such as Price To Sales Ratio of 3.94, Dividend Yield of 0.0 or PTB Ratio of 5.34. Treace financial statements analysis is a perfect complement when working with Treace Medical Valuation or Volatility modules.
Treace | Begin Period Cash Flow |
Latest Treace Medical's Begin Period Cash Flow Growth Pattern
Below is the plot of the Begin Period Cash Flow of Treace Medical Concepts over the last few years. It is the amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. Treace Medical's Begin Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Treace Medical's overall financial position and show how it may be relating to other accounts over time.
| Begin Period Cash Flow | 10 Years Trend |
|
Begin Period Cash Flow |
| Timeline |
Treace Begin Period Cash Flow Regression Statistics
| Arithmetic Mean | 13,524,117 | |
| Geometric Mean | 3,563,883 | |
| Coefficient Of Variation | 202.66 | |
| Mean Deviation | 16,504,839 | |
| Median | 1,284,000 | |
| Standard Deviation | 27,408,397 | |
| Sample Variance | 751.2T | |
| Range | 104.5M | |
| R-Value | 0.56 | |
| Mean Square Error | 553.6T | |
| R-Squared | 0.32 | |
| Significance | 0.03 | |
| Slope | 3,443,287 | |
| Total Sum of Squares | 10517.1T |
Treace Begin Period Cash Flow History
About Treace Medical Financial Statements
Investors use fundamental indicators, such as Treace Medical's Begin Period Cash Flow, to determine how well the company is positioned to perform in the future. Although Treace Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Begin Period Cash Flow | 19.5 M | 34.5 M |
Currently Active Assets on Macroaxis
When determining whether Treace Medical Concepts offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Treace Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Treace Medical Concepts Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Treace Medical Concepts Stock:Check out the analysis of Treace Medical Correlation against competitors. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Treace Medical. If investors know Treace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Treace Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.99) | Revenue Per Share 3.274 | Quarterly Revenue Growth 0.106 | Return On Assets (0.17) | Return On Equity (0.51) |
The market value of Treace Medical Concepts is measured differently than its book value, which is the value of Treace that is recorded on the company's balance sheet. Investors also form their own opinion of Treace Medical's value that differs from its market value or its book value, called intrinsic value, which is Treace Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Treace Medical's market value can be influenced by many factors that don't directly affect Treace Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Treace Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Treace Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Treace Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.